David Young, President Research & Development at Processa Pharmaceuticals, Inc. (PCSA), bought 1,810 shares at $2.54 ($5K) on 2026-03-31, disclosed to the SEC on 2026-04-01.
Seasonal purchase ($5k) by President Research & Development — this insider has traded PCSA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |